Loading...
Loading...
CDNA| Name | Value |
|---|---|
| Revenues | 65.6M |
| Cost of Revenue | 26.3M |
| Gross Profit | 39.3M |
| Operating Expense | 63.2M |
| Operating I/L | -23.9M |
| Other Income/Expense | -94.1M |
| Interest Income | 3.2M |
| Pretax | -117.9M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -118.1M |
CareDx, Inc. specializes in developing and commercializing diagnostic solutions for transplant patients, offering a range of products such as AlloSure Kidney, AlloMap Heart, AlloSure Heart, and AlloSure Lung for various transplant types. Additionally, the company provides TruSight HLA and Olerup SSP for HLA typing, as well as software solutions like Ottr and XynQAPI for transplant patient management. CareDx generates revenue by selling its products directly to customers and through third-party distributors and sub-distributors. The company also has license agreements with Illumina, Inc. for NGS products and technologies, and Cibiltech SAS for the commercialization of iBox software.
